๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Suzhou
Clinical trial register · China

Clinical Trials in Suzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital of Soochow University115 Second Affiliated Hospital of Soochow University16 Capital Medical University9 Novartis Pharmaceuticals8 Takeda8
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Suzhou

421 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .
NCT07242300Upper Limb Spasticity (ULS)
JHM BioPharma (Tonghua) Co. , Ltd.
Phase 3
207
Beijing, Shijiazhuang, Luoyang, Zhengzhou, Changsha, Huai'an, Suzhou, Pingxiang
2025-12-11
Recruiting
Direct Visualization ERAT Versus Laparoscopic Appendectomy in Adults With Acute Uncomplicated Appendicitis
NCT07230379Acute Uncomplicated Appendicitis
Changhai Hospital
Not applicable
376
Chongqing, Guangzhou, Shenzhen, Kaifeng, Zhengzhou, Changsha, Suzhou, Nanchang
2025-12-10
Recruiting
A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
NCT07179679Multiple Myeloma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
42
Chongqing, Guangzhou, Chengde, Tangshan, Nanjing, Suzhou, Nanchang, Xi'an
2025-12-09
Active, closed
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011
NCT07295496Acute Gout Flare
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
64
Suzhou
2025-12-08
Active, closed
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2
NCT07263776Acute Ischemic Stroke
Capital Medical University
Phase 3
692
Suzhou, Zhangzhou, Qinzhou, Langfang, Qinhuangdao, Tangshan, Harbin, Anyang
2025-12-05
Recruiting
Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies
NCT07284927Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1
10
Suzhou
2025-12-03
Recruiting
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
NCT07116031Chronic Graft Versus Host Disease
Sanofi
Phase 2
37
Beijing, Shanghai, Shenzhen, Suzhou
2025-12-02
Recruiting
Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
NCT07258160Solid Cancer, Lymphopenia
Second Affiliated Hospital of Soochow University
Phase 2
127
Suzhou
2025-12-01
Not yet open
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
NCT07238959Benign Prostate Hypertrophy(BPH), Prostate Cancer (Diagnosis), Prostate Neoplasm
Shanghai Changzheng Hospital
Observational
1,100
Beijing, Guangzhou, Nanjing, Suzhou, Shanghai, Chengdu, Ningbo
2025-12
Recruiting
Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL
NCT07255963DLBCL - Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
29
Suzhou
2025-11-30
Recruiting
A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease
NCT07640893Von Willebrand Disease (VWD)
Shanghai RAAS Blood Products Co., Ltd.
Phase 2
24
Changsha, Hefei, Jinan, Nanning, Suzhou, Taiyuan, Tangshan, Tianjin
2025-11-26
Recruiting
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
NCT06921317Primary Open-Angle Glaucoma (POAG)
IVIEW Therapeutics Inc.
Phase 1/2
6
Suzhou
2025-11-19
Recruiting
Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)
NCT07805967Multiple System Atrophy, Dementia With Lewy Bodies (DLB), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
Second Affiliated Hospital of Soochow University
Observational
500
Changshu, Huai'an, Kunshan, Nanjing, Nantong, Suqian, Suzhou, Xuzhou
2025-11-12
Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
NCT07225504Secondary Progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals
Phase 3
1,275
Guangzhou, Zhengzhou, Wuhan, Hohhot, Suzhou, Changchun, Shenyang, Yinchuan
2025-11-11
Recruiting
Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment
NCT07282093Pharmacokinetic, Olverembatinib
Ascentage Pharma Group Inc.
Phase 1
48
Suzhou
2025-11-11
Recruiting
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
NCT07559695Menin Inhibitors, Acute Leukemia, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy
The First Affiliated Hospital of Soochow University
Observational
20
Suzhou
2025-11-01
Recruiting
Intensive Versus Conventional Blood Pressure Control Following Stroke Thrombectomy
NCT07350564Stroke
Hao Yonggang
Not applicable
910
Suzhou
2025-11-01
Recruiting
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
NCT07270835Hemophagocytic Lymphohistiocytosis, B Cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 4
40
Suzhou
2025-11-01
Recruiting
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
NCT07250269Relapsed/Refractory AL Amyloidosis
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1
9
Beijing, Changchun, Guangzhou, Hangzhou, Suzhou, Wenzhou, Wuhan
2025-10-29
Active, closed
A Phase โ…  b Clinical Study of ART101 Injection
NCT07614308Hypertension (HTN)
Arnatar Therapeutics, Inc.
Phase 1
16
Suzhou
2025-10-27
Recruiting
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
NCT07208097Intracerebral Haemorrhage, Minimally Invasive Treatment
Tongji Hospital
Not applicable
768
Suzhou, Guiyang
2025-10-25
Recruiting
Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naรฏve MZL.
NCT07372365Marginal Zone Lymphoma (MZL)
The First Affiliated Hospital of Soochow University
Phase 2
23
Suzhou
2025-10-24
Recruiting
A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
NCT07095075Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.
Phase EARLY_PHASE1
36
Bengbu, Hefei, Nanjing, Suzhou, Wenzhou
2025-10-14
Recruiting
Observational Study on the Impact of Obstructive Sleep Apnea on Executive Function and Empathy Development in Children
NCT06850220Pediatric Obstructive Sleep Apnea, Cognition, Empathy, EEG
Children's Hospital of Soochow University
Observational
150
Suzhou
2025-10-13
Recruiting
A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
NCT07129343Von Willebrand Disease (VWD)
Takeda
Phase 3
20
Beijing, Guangzhou, Jihan, Shanghai, Suzhou, Tianjin, Wuhan
2025-10-13
Recruiting
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT06988488Multiple Myeloma
Celgene
Phase 1/2
62
Suzhou, Shanghai
2025-10-07
Recruiting
A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia
NCT07499284Aplastic Anaemia
The First Affiliated Hospital of Soochow University
Not applicable
224
Suzhou, Xuzhou, Hangzhou
2025-10-01
Recruiting
Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)
NCT07198386NASH
Cascade Pharmaceuticals, Inc
Phase 2
120
Fuzhou, Xiamen, Suzhou, Shanghai, Hangzhou, Wenzhou
2025-09-30
Recruiting
Effectiveness of School-Based Time-Restricted Eating for the Prevention and Control of Obesity in Children
NCT07184281Childhood Obesity, Childhood Obesity Pevention
Children's Hospital of Soochow University
Not applicable
1,380
Suzhou
2025-09-26
Recruiting
PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
NCT07188610CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 2
100
Hefei, Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing, Suzhou
2025-09-25
Recruiting
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
NCT07172204Intensive Chemotherapy Unfit, Newly Diagnosed Acute Myeloid Leukemia (AML), Age โ‰ฅ60
First Affiliated Hospital of Zhejiang University
Phase 2
25
Beijing, Shenzhen, Suzhou, Nanchang, Hangzhou
2025-09-16
Recruiting
Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML
NCT07451912Acute Myeloid Leukemia (AML), CEBPA Mutation, Unfit, New-diagnosis AML
The First Affiliated Hospital of Soochow University
Phase 1/2
29
Suzhou
2025-09-15
Recruiting
Health Chat for Empowerment-based Lifestyle Planning for Cardiometabolic Multimorbidity
NCT07158697Cardiometabolic Diseases, Multimorbidity
The University of Hong Kong
Not applicable
232
Suzhou
2025-09-08
Recruiting
Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia
NCT07206823Primacy Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University
Not applicable
30
Suzhou
2025-09-01
Recruiting
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
NCT07159620Adult T-cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
27
Suzhou
2025-09-01
Recruiting
Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease
NCT07068438Chronic Bronchitis, COPD (Chronic Obstructive Pulmonary Disease)
Suzhou Hengruihongyuan Medical Technology Co. LTD
Not applicable
210
Hefei, Beijing, Changzhou, Suzhou, Wuxi, Xuzhou, Nanchang, Hangzhou
2025-09-01
Not yet open
Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency
NCT07126288Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD), Growth Hormone
Shenzhen Kexing Pharmaceutical Co., Ltd.
Phase 2/3
268
Xiamen, Nanyang, Xinxiang, Wuhan, Suzhou, Nanchang, Pingxiang, Changchun
2025-08-31
Recruiting
Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke
NCT07095790Mild Stroke
Second Affiliated Hospital of Soochow University
Phase 4
580
Suzhou, Shijiazhuang, Zhoukou, Bayan Nur, Huai'an, Suqian, Taizhou, Xi'an
2025-08-30
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
NCT07086976Autoimmune Haemolytic Anaemia
Sanofi
Phase 3
90
Beijing, Chengde, Guangzhou, Hohhot, Nanchang, Suzhou, Tianjin, Wuhan
2025-08-18
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06948318Immune Thrombocytopenic Purpura (ITP)
Takeda
Phase 3
150
Beijing, Guangzhou, Nanning, Shijiazhuang, Wuhan, Zhengzhou, Suzhou, Nanchang
2025-08-14
Recruiting
Interventional Left Ventricular Assist System for PCI in CHIP Patients
NCT07053618High-Risk Percutaneous Coronary Intervention (High-risk PCI), Left Ventricular Assist Devices
Suzhou Hengruihongyuan Medical Technology Co. LTD
Not applicable
286
Beijing, Xiamen, Lanzhou, Guangzhou, Zhengzhou, Changsha, Suzhou, Nanchang
2025-08-06
Recruiting
Probiotics and Non-Organic Gastrointestinal Improvement
NCT07081100Gastrointestinal Function
Wecare Probiotics Co., Ltd.
Not applicable
50
Suzhou
2025-08-05
Recruiting
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
NCT07101497Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy, Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2025-08-01
Recruiting
Safety and Efficacy of RN1201 Injection as First-Line Treatment for Newly Diagnosed Multiple Myeloma
NCT07652138Multiple Myloma, Newly Diagnosed Multiple Myeloma (NDMM)
The First Affiliated Hospital of Soochow University
Phase 1
18
Suzhou
2025-07-30
Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
NCT06911502Follicular Lymphoma
Celgene
Phase 3
400
Beijing, Fuzhou Fujian, Guangzhou, Harbin, Wuhan, Changsha, Hohhot, Suzhou
2025-07-28
Recruiting
A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia
NCT06730256Relapsed/Refractory Plasma Cell Leukemia, Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
24
Suzhou
2025-07-23
Recruiting
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
NCT07015762Atopic Dermatitis
The First Affiliated Hospital of Soochow University
Phase 1
9
Suzhou
2025-07-14
Active, closed
Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
NCT07239544Lung Cancer (NSCLC)
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2025-07-10
Not yet open
Chinese Art Activities or Combined With Peer Group Participation on Psychological Well Being
NCT06841133Aging
Prince of Songkla University
Not applicable
90
Suzhou
2025-07-09
Recruiting
RN1201 Injection in the Treatment of Antibody-Mediated Diseases
NCT07072247Refractory Immune-mediated Platelet Transfusion Refractoriness, Relapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University
Phase 1
9
Suzhou
2025-07-07
Recruiting
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
NCT06975722Ulcerative Colitis
Sanofi
Phase 2
99
Huizhou, Guangzhou, Nanjing, Suzhou, Wuxi, Shanghai, Hangzhou, Ningbo
2025-07-07
By invitation
Clinical Study of 68Ga-labeled Novel Nectin-4 Bicyclic Peptide PET/CT for Imaging of Solid Tumors With High Nectin-4 Expression
NCT07319130Solid Tumors With High Expression of Nectin4
The First Affiliated Hospital of Soochow University
Not applicable
10
Suzhou
2025-07-03
Recruiting
Clinical Study of U32 in Patients With Acute Myeloid Leukemia
NCT07036250Acute Myeloid Leukaemia
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1/2
20
Suzhou
2025-07-03
By invitation
A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque
NCT07050134Hypertriglyceridemia, Carotid Atherosclerotic Plaques
Junbo Ge
Not applicable
40
Hefei, Suzhou, Shanghai
2025-07-01
Active, closed
Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity
NCT06975501Hypertension, Type 2 Diabetes Mellitus (T2DM), Multimorbidity, Stroke
Duke Kunshan University
Not applicable
444
Suzhou
2025-06-20
Recruiting
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma
NCT07015749Asthma
The First Affiliated Hospital of Soochow University
Phase 1
12
Suzhou
2025-06-20
Recruiting
The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction
NCT06995118Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Du Zhenggui
Not applicable
337
Fuzhou, Guangzhou, Anyang, Zhengzhou, Changsha, Hohhot, Suzhou, Nanchang
2025-06-17
Recruiting
Selinexor, High-dose Methotrexate, and Rituximab Combined With Radiotherapy for Newly Diagnosed, Transplant-ineligible Patients With Central Nervous System Lymphoma: An Open-label, Single-arm, Multicenter Phase II Study
NCT07002099Lymphomas
Second Affiliated Hospital of Soochow University
Phase 2
26
Suzhou
2025-06-01
Recruiting
Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos
NCT07098884Artificial Intelligence, Lung Nodule
Anhui Provincial Hospital
Observational
600
Hefei, Suzhou, Ningbo
2025-06-01
Not yet open
Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis
NCT06951971Hemophagocytic Lymphohistiocytosis (HLH)
The First Affiliated Hospital of Soochow University
Phase 2/3
30
Suzhou
2025-06-01
Recruiting
Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
NCT07047573Lung Cancer (Diagnosis), Pulmonary Nodule Persistent
Zhao Jun
Observational
150
Suzhou
2025-06-01
Recruiting
a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
NCT07007949Acute Myeloid Leukemia, IDH1 Gene Mutation, Ivosidenib
The First Affiliated Hospital of Soochow University
Phase 2
42
Suzhou
2025-06-01
Not yet open
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
NCT07003178Non Hodgkin Lymphoma
Starna Therapeutics
Phase EARLY_PHASE1
30
Suzhou
2025-06
Recruiting
Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III
NCT06971094SMA - Spinal Muscular Atrophy
GeneCradle Inc
Phase 3
50
Beijing, Shanghai, Shenzhen, Suzhou, Wuhan
2025-05-27
Recruiting
Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
NCT07562542Systemic Mastocytosis, KIT-D816V Mutation
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2025-05-19
Not yet open
Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT06970951Systemic Lupus Erythematosus, Rheumatoid Arthritis, Dry Syndrome, Idiopathic Inflammatory Myopathies
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1
15
Suzhou
2025-05-18
Recruiting
Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy
NCT06985485Acute Lymphoblastic Leukemia, Immunotherapy, Blinatumomab, Inotuzumab Ozogamicin
The First Affiliated Hospital of Soochow University
Phase 2
26
Suzhou
2025-05-17
Recruiting
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
NCT07028073Acute Myeloid Leukemia With T(8;21)(Q22;Q22), Acute Myeloid Leukemia With T(16;16)(P13;Q22), KIT Gene Mutation, Avapritinib
The First Affiliated Hospital of Soochow University
Phase 1/2
78
Suzhou
2025-05-15
Active, closed
Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome
NCT06963840Polycystic Ovarian Syndrome (PCOS)
Wellizen Australia
Phase 2
16
Suzhou
2025-05-09
Recruiting
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
NCT07552285Prostate Cancer, Prostate Cancer (Diagnosis)
The First Affiliated Hospital of Soochow University
Observational
300
Suzhou
2025-05-01
Recruiting
Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial
NCT06773364Suspected Stroke
Shanghai East Hospital
Phase 3
2,423
Suzhou, Shanghai
2025-04-30
Recruiting
Dapagliflozin in Allo-HCT for aGVHD
NCT06626737Graft-versus-host Disease (GVHD)
The First Affiliated Hospital of Soochow University
Phase 2
72
Suzhou
2025-04-26
Recruiting
Efficacy of Lactobacillus Rhamnosus LRa05 in Gestational Diabetes
NCT06901791GDM
Wecare Probiotics Co., Ltd.
Not applicable
80
Suzhou
2025-04-10
Not yet open
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
NCT06838520Prostate Cancer (Adenocarcinoma)
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Changzhou, Nanjing, Suzhou, Yangzhou
2025-04-01
Recruiting
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
NCT07012447Early T Acute Lymphoblastic Leukemia, T-Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T/Myeloid, Nos
yuejun Liu
Phase 2
32
Suzhou
2025-04-01
Recruiting
Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
NCT07564453B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
The First Affiliated Hospital of Soochow University
Phase 2
101
Suzhou
2025-04-01
Not yet open
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment
NCT06922929Prostate Cancer Recurrent
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
110
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Not yet open
Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.
NCT06922903Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
240
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Recruiting
Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
NCT06882577Acute Ischemic Stroke
Soochow University
Observational
400
Suzhou
2025-03-31
Active, closed
A Multifaceted Intervention to Reduce Obesity Among Preschool Children: Study Protocol for a Randomized Controlled Trial in Suzhou City
NCT07361211Children, Obesity & Overweight, Intervention
Soochow University
Not applicable
1,486
Suzhou
2025-03-24
Recruiting
Intradermal Acupuncture and Self-rehabilitation Program in Patients With Severe Bell's Palsy
NCT06778473Bell Palsy
Zhangjiagang First People's Hospital
Not applicable
552
Suzhou
2025-03-24
Recruiting
A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement
NCT06985615Hepatic Impairment, Healthy Volunteers
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
40
Suzhou
2025-03-18
Active, closed
cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia
NCT06686485Concomitant Procedures, Atrial Fibrillation, PFA, LAAC
Boston Scientific Corporation
Observational
433
Suzhou, Beijing, Chengdu, Guangzhou, Guiyang, Hangzhou, Jinan, Kunming
2025-03-18
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
NCT06641466Menstrual Migraine
Pfizer
Phase 3
723
Beijing, Chongqing, Shijiazhuang, Nanjing, Suzhou, Xi'an, Xianyang, Shanghai
2025-03-11
Not yet open
Deep Sedation in Catheter Ablation of Atrial Fibrillation
NCT06836999Atrial Fibrillation, Atrial Fibrillation, Paroxysmal or Persistent, Deep Sedations, Conscious Sedation
The First Affiliated Hospital of Dalian Medical University
Not applicable
1,334
Hefei, Guangzhou, Nanjing, Suzhou, Nanchang, Dalian, Qingdao, Shanghai
2025-03-03
Not yet open
Validation Study of Simplified Chinese Version of LOTCA Scale in the Assessment of Cognitive Impairment in Patients with Traumatic Brain Injury
NCT06850584Traumatic Brain Injury
Nanjing Broad Biopharmaceutical Ltd.
Observational
300
Huaian, Suzhou, Xuzhou, Yangzhou
2025-03-01
Not yet open
Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients
NCT06849011Stroke Acute, Encephalitis, Non-traumatic Brain Injury
Yan Zhang
Observational
1,185
Beijing, Lanzhou, Guiyang, Zunyi, Tangshan, Shijiazhuang, Hohhot, Suzhou
2025-03-01
Recruiting
A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology
NCT07050537Fertility Issues, Blastocyst IVF, Embryo Culture
The First Affiliated Hospital with Nanjing Medical University
Not applicable
980
Zhengzhou, Changzhou, Nanjing, Suzhou, Xiโ€™an
2025-03-01
Recruiting
Peginterferon ฮฑ-2b Injection for the Treatment of Pediatric RSV Bronchiolitis
NCT06827249Bronchiolitis
Children's Hospital of Soochow University
Not applicable
90
Wuhan, Suzhou, Changchun
2025-03
Recruiting
Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects
NCT06867393Healthy Subjects
Shanghai Kechow Pharma, Inc.
Phase 1
52
Suzhou
2025-02-28
Recruiting
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06722235Immune Thrombocytopenic Purpura (ITP)
Takeda
Phase 3
171
Beijing, Guangzhou, Nanning, Shijiazhuang, Wuhan, Zhengzhou, Suzhou, Nanchang
2025-02-27
By invitation
Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of YD0293 in Healthy Subjects
NCT07098091Healthy Participants
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase 1
78
Suzhou
2025-02-26
Recruiting
Exploring the Potential Benefits of Probiotic Yogurt
NCT06847919Chronic Constipation
Wecare Probiotics Co., Ltd.
Not applicable
84
Suzhou
2025-02-25
Not yet open
Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naรฏve Participants With Acute Myeloid Leukemia
NCT06841952AML, Adult
The First Affiliated Hospital of Soochow University
Not applicable
158
Suzhou
2025-02-15
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
NCT06858579Chronic Inflammatory Demyelinating Polyneuropathy
Dianthus Therapeutics
Phase 3
256
Hefei, Guangzhou, Changsha, Wuhan, Chifeng, Suzhou, Beijing, Chengdu
2025-02-10
Active, closed
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
NCT06806293Menstrual Migraine (MM)
AbbVie
Phase 3
468
Beijing, Guangzhou, Shijiazhuang, Wuhan, Suzhou, Xi'an, Taiyuan, Tianjin
2025-02-10
Recruiting
The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders
NCT06797284Insomnia Chronic, Narcolepsy, REM Sleep Behavior Disorder
Second Affiliated Hospital of Soochow University
Not applicable
20
Suzhou
2025-02-01
Recruiting
Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
NCT06816134Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Transplantation, Stem Cell, Conditioning Therapy
The First Affiliated Hospital of Soochow University
Phase 2
48
Suzhou
2025-01-30
Not yet open
The Impact of Thoracic Paravertebral Nerve Block At Different Positions on Pain Relief in Patients Undergoing Single-Port Thoracoscopic Partial Lung Resection
NCT06789276Lung Nodules, Lung Cancer
Second Affiliated Hospital of Soochow University
Not applicable
200
Suzhou
2025-01-18
Recruiting
Prospective Evaluation of the 2022 Optic Neuritis Criteria When Optic Neuritis Is Suspected
NCT07623252Optic Neuritis, Optic Neuropathy, Visual Loss
First Affiliated Hospital of Guangxi Medical University
Observational
500
Nanning, Qinzhou, Wuzhou, Yulin, Suzhou
2025-01-06
Rows per page Showing 101–200 of 421
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/suzhou?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 421 of those studies with a site in Suzhou.

How many clinical trials are recruiting in Suzhou?

269 of the 421 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 53 have not yet opened recruitment, 87 are active but closed to new participants, and 12 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.